Late Complications in acute Leukemia Patients following HSCT: A single center experience

Background: Hematopoietic stem cell transplantation (HSCT) is currently the only curative treatment for acute leukemia. As HSCT improves the long-term survival, it is necessary to assess the late-onset complications affecting the quality of life following HSCT. Subjects and Methods: The study includ...

Full description

Bibliographic Details
Main Authors: Mohammad Vaezi, Cyrous Gharib, Maryam Souri, Ardeshir Ghavamzadeh
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2016-04-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Online Access:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/481
id doaj-a882e96b4dd64c7cb8a1276bd34c92f3
record_format Article
spelling doaj-a882e96b4dd64c7cb8a1276bd34c92f32020-11-25T04:08:36ZengTehran University of Medical SciencesInternational Journal of Hematology-Oncology and Stem Cell Research2008-22072016-04-01101Late Complications in acute Leukemia Patients following HSCT: A single center experienceMohammad Vaezi0Cyrous Gharib1Maryam Souri2Ardeshir Ghavamzadeh3Hematologist-Oncologist, Hematology- Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, IranHematologist-Oncologist, Gilan University of Medical Sciences, Gilan, Iran3Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, IranProfessor of Medicine, Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, IranBackground: Hematopoietic stem cell transplantation (HSCT) is currently the only curative treatment for acute leukemia. As HSCT improves the long-term survival, it is necessary to assess the late-onset complications affecting the quality of life following HSCT. Subjects and Methods: The study included 122 patients (65 male, 57 female) with leukemia (72 AML and 50 ALL) who received transplants from fully- matched siblings, unrelated donors and unrelated cord blood donors between February 2013 and August 2014 in Shariati Hospital. All study participants were over 18 years of age and had the minimum and maximum survival of 2 and 5 years, respectively. Patients who received HLA-haploidentical SCT were excluded from the study. All allogeneic recipients received busulfan and cyclophosphamide as conditioning regimen. Nobody received TBI-based conditioning regimen in this study. Patients were evaluated for cardiovascular, vision, psychological, endocrine, fertility problems and secondary malignancies one year after transplantation. Results: Data were analyzed using SPSS 15.0. Mitral and tricuspid regurgitation (TR/MR) were the most common cardiac complications (n=12, 10.5%).Thirty-nine percent of patients had psychological problems, especially depression (34%). Cataract was observed in 13% of patients and 34% complained of dry eye. Symptomatic pulmonary changes were found in 13 patients (10.6%). None of the HSCT survivors had experienced fertility before study entry. According to LH and FSH levels, 15% and 9% of females had ovarian failure, respectively. Testosterone level was less than normal in 49(84%) men and, according to their FSH and LH level, 20 (41%) had secondary hypogonadism and 29 (59%) had primary gonadal dysfunction. Conclusion: The results showed that patients who received Bu/Cy conditioning regimen experienced fewer late side effects such as cataract formation and hypothyroidism, compared to previous studies using TBI-based conditioning regimen. https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/481Hematopoietic Stem Cell Transplantation (HSCT)Late ComplicationsTBI / BuCy Regimens
collection DOAJ
language English
format Article
sources DOAJ
author Mohammad Vaezi
Cyrous Gharib
Maryam Souri
Ardeshir Ghavamzadeh
spellingShingle Mohammad Vaezi
Cyrous Gharib
Maryam Souri
Ardeshir Ghavamzadeh
Late Complications in acute Leukemia Patients following HSCT: A single center experience
International Journal of Hematology-Oncology and Stem Cell Research
Hematopoietic Stem Cell Transplantation (HSCT)
Late Complications
TBI / BuCy Regimens
author_facet Mohammad Vaezi
Cyrous Gharib
Maryam Souri
Ardeshir Ghavamzadeh
author_sort Mohammad Vaezi
title Late Complications in acute Leukemia Patients following HSCT: A single center experience
title_short Late Complications in acute Leukemia Patients following HSCT: A single center experience
title_full Late Complications in acute Leukemia Patients following HSCT: A single center experience
title_fullStr Late Complications in acute Leukemia Patients following HSCT: A single center experience
title_full_unstemmed Late Complications in acute Leukemia Patients following HSCT: A single center experience
title_sort late complications in acute leukemia patients following hsct: a single center experience
publisher Tehran University of Medical Sciences
series International Journal of Hematology-Oncology and Stem Cell Research
issn 2008-2207
publishDate 2016-04-01
description Background: Hematopoietic stem cell transplantation (HSCT) is currently the only curative treatment for acute leukemia. As HSCT improves the long-term survival, it is necessary to assess the late-onset complications affecting the quality of life following HSCT. Subjects and Methods: The study included 122 patients (65 male, 57 female) with leukemia (72 AML and 50 ALL) who received transplants from fully- matched siblings, unrelated donors and unrelated cord blood donors between February 2013 and August 2014 in Shariati Hospital. All study participants were over 18 years of age and had the minimum and maximum survival of 2 and 5 years, respectively. Patients who received HLA-haploidentical SCT were excluded from the study. All allogeneic recipients received busulfan and cyclophosphamide as conditioning regimen. Nobody received TBI-based conditioning regimen in this study. Patients were evaluated for cardiovascular, vision, psychological, endocrine, fertility problems and secondary malignancies one year after transplantation. Results: Data were analyzed using SPSS 15.0. Mitral and tricuspid regurgitation (TR/MR) were the most common cardiac complications (n=12, 10.5%).Thirty-nine percent of patients had psychological problems, especially depression (34%). Cataract was observed in 13% of patients and 34% complained of dry eye. Symptomatic pulmonary changes were found in 13 patients (10.6%). None of the HSCT survivors had experienced fertility before study entry. According to LH and FSH levels, 15% and 9% of females had ovarian failure, respectively. Testosterone level was less than normal in 49(84%) men and, according to their FSH and LH level, 20 (41%) had secondary hypogonadism and 29 (59%) had primary gonadal dysfunction. Conclusion: The results showed that patients who received Bu/Cy conditioning regimen experienced fewer late side effects such as cataract formation and hypothyroidism, compared to previous studies using TBI-based conditioning regimen.
topic Hematopoietic Stem Cell Transplantation (HSCT)
Late Complications
TBI / BuCy Regimens
url https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/481
work_keys_str_mv AT mohammadvaezi latecomplicationsinacuteleukemiapatientsfollowinghsctasinglecenterexperience
AT cyrousgharib latecomplicationsinacuteleukemiapatientsfollowinghsctasinglecenterexperience
AT maryamsouri latecomplicationsinacuteleukemiapatientsfollowinghsctasinglecenterexperience
AT ardeshirghavamzadeh latecomplicationsinacuteleukemiapatientsfollowinghsctasinglecenterexperience
_version_ 1724424986219773952